February 18, 2026

GSK’s RSV Vaccine Moves Closer to China Approval 

Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year

The Medicine Maker

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

January 26, 2026

Speed Saves Lungs

Why rapid diagnostics matter during cold and flu season

The Pathologist

January 20, 2026

How Speed, Scale, and Science Can Personalize the Pandemic Response

Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.

The Medicine Maker

January 12, 2026

Medable Debuts AI Agent for Automating Trial Master File Processes

New capability frees up human capital from one of the biggest labor costs in clinical research

The Medicine Maker

January 05, 2026

HRSA Adds Self-Collection to Screening

Updated guidelines position patient-collected testing as an option for patients aged 30 to 65 years who are at average risk of cervical cancer, with mandatory insurance coverage beginning January 2027

Conexiant

December 19, 2025

From Cough to Clarity: Expanding the Respiratory Testing Toolkit

Is it time to expand the menu of testing options for respiratory infections?

The Pathologist

December 19, 2025

Europe’s Hidden HIV Burden

Surveillance suggests thousands may remain undiagnosed as late-stage presentations persist

The Pathologist

December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant